Expression and amplification of cyclin genes in human breast cancer.
Michael F. Buckley(Prince of Wales Hospital), R. Sutherland, Anna DeFazio(The University of Sydney), John A. Hamilton(The Royal Melbourne Hospital), Elizabeth A. Musgrove(University of Helsinki), C. K. W. Watts, David L. Manning, R. L. Sini, Robert I. Nicholson(Cardiff University), Kimberley J. E. Sweeney
PubMed
August 1, 1993
Cited by 676
Related Papers
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
|Clinical Cancer Research|2008|1.5k
<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
|Journal of Clinical Oncology|2012|1.2k
Driver mutations in <i>TP53</i> are ubiquitous in high grade serous carcinoma of the ovary
|The Journal of Pathology|2010|836
Mutation of <i>FOXL2</i> in Granulosa-Cell Tumors of the Ovary
|New England Journal of Medicine|2009|775